Jesus F Bermejo-Martin
Overview
Explore the profile of Jesus F Bermejo-Martin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
3703
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hagman K, Postigo T, Diez-Castro D, Ursing J, Bermejo-Martin J, de la Fuente A, et al.
Lancet Microbe
. 2024 Sep;
6(2):100967.
PMID: 39342950
In this Review, we analysed the prevalence of viraemia during infection with SARS-CoV-2 and other relevant respiratory viruses, including other human coronaviruses such as MERS-CoV and SARS-CoV, adenovirus, human metapneumovirus,...
2.
Bruse N, Motos A, van Amstel R, De Bie E, Kooistra E, Jansen A, et al.
Intensive Care Med
. 2024 Aug;
50(11):1884-1896.
PMID: 39186112
Purpose: Disease heterogeneity in coronavirus disease 2019 (COVID-19) may render the current one-size-fits-all treatment approach suboptimal. We aimed to identify and immunologically characterize clinical phenotypes among critically ill COVID-19 patients,...
3.
de la Fuente A, Lopez-Sanchez J, Vaquero-Roncero L, Merino Garcia M, Sanchez Barrado M, Sanchez-Hernandez M, et al.
Int J Infect Dis
. 2024 Jun;
146:107142.
PMID: 38901729
Objectives: Identifying host response biomarkers implicated in the emergence of organ failure during infection is key to improving the early detection of this complication. Methods: Twenty biomarkers of innate immunity,...
4.
de la Fuente A, Postigo T, Sanus Ferri F, Dominguez-Gil M, Alvarez-Manzanares J, Eiros J, et al.
Int J Infect Dis
. 2024 Feb;
140:132-135.
PMID: 38311026
Objectives: Identifying patients with COVID-19 who are at risk of poor evolution is key to early decide on their hospitalization. We evaluated the combined impact of nucleocapsid (N)-antigenemia profiled by...
5.
Cajander S, Kox M, Scicluna B, Weigand M, Mora R, Flohe S, et al.
Lancet Respir Med
. 2023 Dec;
12(4):305-322.
PMID: 38142698
Sepsis is characterised by a dysregulated host immune response to infection. Despite recognition of its significance, immune status monitoring is not implemented in clinical practice due in part to the...
6.
Tedim A, Merino I, Ortega A, Dominguez-Gil M, Eiros J, Bermejo-Martin J
Diagn Microbiol Infect Dis
. 2023 Oct;
108(1):116075.
PMID: 37837915
We used droplet digital PCR (ddPCR) assays to detect/quantify DNA from Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Enterococcus spp. in blood samples. Bacterial DNA from clinical strains (4 <...
7.
Gomez-Sanchez L, Tamayo-Morales O, Suarez-Moreno N, Bermejo-Martin J, Dominguez-Martin A, Martin-Oterino J, et al.
Front Physiol
. 2023 Sep;
14:1236430.
PMID: 37772064
SARS-CoV-2 infection affects the vascular endothelium, which mediates the inflammatory and thrombotic cascade. Moreover, alterations in the endothelium are related to arterial stiffness, which has been established as a marker...
8.
Martin-Loeches I, Martinez G, Garduno A, Cusack R, Andaluz-Ojeda D, Lopez-Campos G, et al.
Expert Rev Anti Infect Ther
. 2023 Sep;
21(10):1135-1141.
PMID: 37676034
Background: Ventilator-associated pneumonia (VAP) represents a transitory status of immunoparalysis, and we hypothesized that ventilator-associated tracheobronchitis (VAT) could share also some degree of immune response to a respiratory infection. Research...
9.
Galli F, Bindo F, Motos A, Fernandez-Barat L, Barbeta E, Gabarrus A, et al.
Intensive Care Med
. 2023 Jul;
49(8):934-945.
PMID: 37507573
Purpose: Although the prevalence of community-acquired respiratory bacterial coinfection upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been reported to be < 5%, almost three-quarters of patients...
10.
de Gonzalo-Calvo D, Molinero M, Benitez I, Perez-Pons M, Garcia-Mateo N, Ortega A, et al.
Respir Res
. 2023 Jun;
24(1):159.
PMID: 37328754
Background: The identification of critically ill COVID-19 patients at risk of fatal outcomes remains a challenge. Here, we first validated candidate microRNAs (miRNAs) as biomarkers for clinical decision-making in critically...